An integrated system pharmacology analysis then revealed that various targets such as PPARG, RELA, EGFR and numerous pathways such as TNF signalling, PI3K-Akt signalling, MAPK signalling and NF-κB signalling were involved in the underlying mechanisms of GQD in improving diabetic insulin resistance (89). The gene discussed is NFKB1; the disease is Insulin resistance.